“Immune Checkpoint Inhibitor-Associated Myocarditis Presenting as Isolated High-Grade Atrioventricular Block: A Review of Surveillance Strategies”, JCCSR, vol. 3, no. 1, pp. 31–36, Jun. 2022, doi: 10.5281/zenodo.22205984.